# Correction: Secondary metabolites from Lobaria pulmonaria (L.) Hoffm. target key metabolic enzymes: a novel strategy against multidrug-resistant tuberculosis

**Authors:** Ha Thi Nguyen, Vishnu Nayak Badavath, Siddhartha Maji, Haritha Polimati, Emmanuel Okello, Richard A. Bunce, Nguyen Huy Thuan, Wan Mohd Nuzul Hakimi Wan Salleh, Vinay Bharadwaj Tatipamula

PMC · DOI: 10.1039/d6ra90025a · RSC Advances · 2026-03-02

## TL;DR

This paper corrects a previous study on natural compounds from a lichen that may help fight drug-resistant tuberculosis.

## Contribution

The paper provides corrections to prior research on the potential of Lobaria pulmonaria metabolites against tuberculosis.

## Key findings

- The original study's findings on enzyme-targeting metabolites are being corrected.
- The corrections address errors in the prior research on multidrug-resistant tuberculosis strategies.

## Abstract

Correction for ‘Secondary metabolites from Lobaria pulmonaria (L.) Hoffm. target key metabolic enzymes: a novel strategy against multidrug-resistant tuberculosis’ by Ha Thi Nguyen et al., RSC Adv., 2026, 16, 8960–8970, https://doi.org/10.1039/D5RA05774D.

## Linked entities

- **Diseases:** multidrug-resistant tuberculosis (MONDO:0005861)

## Full-text entities

- **Diseases:** tuberculosis (MESH:D014376)
- **Species:** Lobaria pulmonaria (lung lichen, species) [taxon 86794]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12951841/full.md

---
Source: https://tomesphere.com/paper/PMC12951841